Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | FAAH | O00519 | 2/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2153681 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL14337652 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL495540 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL3227000 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL1676895 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL17369100 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL1489327 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL14616447 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL2153965 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL2155121 | 1.00 | HIF1A (0.75) | HIF1ATSHRFAAHTRPV1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119368144-A | ZIF-67 nanostructure-containing high-performance photocatalysis synergistic adsorption material and preparation method and application thereof | 陕西科技大学 | 2025-01-28 | — | — | CN | claimed |
| CN-118307789-A | Resin microsphere for blood perfusion and preparation method and application thereof | 河南驼人医疗器械研究院有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118047880-A | Fusion protein based on shiga toxin, cross-linked pentameric protein scaffold, and preparation and application thereof | 江南大学 | 2024-05-17 | — | — | CN | claimed |
| CN-117963883-A | Biological-asphalt-based composite hard carbon composite material and preparation method thereof | 丰镇市宏升炭素有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-20190112348-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK AS (DK) | 2019-04-18 | — | — | US | claimed |
| US-10259856-B2 | Protease stabilized acylated insulin analogues | NOVO NORDISK A/S (DK) | 2019-04-16 | — | — | US | claimed |
| US-9688737-B2 | Protease stabilized acylated insulin analogues | NOVO NORDISK A/S (DK) | 2017-06-27 | — | — | US | claimed |
| EP-2254906-B1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK AS (DK) | 2016-10-05 | — | — | EP | claimed |
| EP-2910571-A1 | Protease stabilized, acylated insulin analogues | Novo Nordisk A/S (DK) | 2015-08-26 | — | — | EP | claimed |
| US-20150210748-A1 | PROTEASE STABILIZED ACYLATED INSULIN ANALOGUES | NOVO NORDISK AS (DK) | 2015-07-30 | — | — | US | claimed |
| US-20150210747-A1 | PROTEASE STABILIZED ACYLATED INSULIN ANALOGUES | NOVO NORDISK AS (DK) | 2015-07-30 | — | — | US | claimed |
| US-20110105720-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK A/S (DK) | 2011-05-05 | — | — | US | claimed |
| EP-2254906-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | Novo Nordisk A/S (DK) | 2010-12-01 | — | — | EP | claimed |
| WO-2009115469-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK A/S (DK) | 2009-09-24 | — | — | WO | claimed |
| CN-1206202-C | Method for mfg. dien | KURARAY CO (JP) | 2005-06-15 | — | — | CN | claimed |
| CN-1446793-A | Method for mfg. dien | KURARAY CO (JP) | 2003-10-08 | — | — | CN | claimed |
| CN-119368144-A | ZIF-67 nanostructure-containing high-performance photocatalysis synergistic adsorption material and preparation method and application thereof | 陕西科技大学 | 2025-01-28 | — | — | CN | disclosed |
| CN-118307789-A | Resin microsphere for blood perfusion and preparation method and application thereof | 河南驼人医疗器械研究院有限公司 | 2024-07-09 | — | — | CN | disclosed |
| EP-0374269-A1 | Amine thiocyanates as accelerators for cure of polyepoxide-polyimine materials | Ashland Oil, Inc. (US) | 1990-06-27 | — | — | EP | disclosed |
| US-4775735-A | SHELF STABILITY, QUICK-SETTING | ASHLAND OIL, INC. (US) | 1988-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210747-A1 | PROTEASE STABILIZED ACYLATED INSULIN ANALOGUES | IAPP, IDE, LIPE | HIF1A 2353/4885TSHR 807/4885FAAH 224/4885 |
| US-20110105720-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | IAPP, IDE, LIPE | HIF1A 1903/4885TSHR 819/4885FAAH 179/4885 |
| US-20150210748-A1 | PROTEASE STABILIZED ACYLATED INSULIN ANALOGUES | IAPP, IDE, LIPE | HIF1A 2353/4885TSHR 807/4885FAAH 224/4885 |
| US-20190112348-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | IAPP, IDE, LIPE | HIF1A 1903/4885TSHR 819/4885FAAH 179/4885 |
| US-10259856-B2 | Protease stabilized acylated insulin analogues | IAPP, IDE, LIPE | HIF1A 2353/4885TSHR 807/4885FAAH 224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.